136 related articles for article (PubMed ID: 9294828)
1. Secreted protein acidic and rich in cysteine expression after subtotal nephrectomy and blockade of the renin-angiotensin system.
Wu LL; Cox A; Roe CJ; Dziadek M; Cooper ME; Gilbert RE
J Am Soc Nephrol; 1997 Sep; 8(9):1373-82. PubMed ID: 9294828
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
[TBL] [Abstract][Full Text] [Related]
3. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
[TBL] [Abstract][Full Text] [Related]
5. Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition.
Velkoska E; Dean RG; Burchill L; Levidiotis V; Burrell LM
Clin Sci (Lond); 2010 Feb; 118(4):269-79. PubMed ID: 19698082
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury.
Cao Z; Bonnet F; Candido R; Nesteroff SP; Burns WC; Kawachi H; Shimizu F; Carey RM; De Gasparo M; Cooper ME
J Am Soc Nephrol; 2002 Jul; 13(7):1773-87. PubMed ID: 12089373
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
[TBL] [Abstract][Full Text] [Related]
8. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
[TBL] [Abstract][Full Text] [Related]
9. Secreted protein acidic and rich in cysteine (SPARC) and a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) increments by the renin-angiotensin system induce renal fibrosis in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Ikemoto MJ; Kobara M; Nakata T
Eur J Pharmacol; 2022 Jan; 914():174681. PubMed ID: 34871556
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system.
Wu LL; Cox A; Roe CJ; Dziadek M; Cooper ME; Gilbert RE
Kidney Int; 1997 May; 51(5):1553-67. PubMed ID: 9150473
[TBL] [Abstract][Full Text] [Related]
11. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
[TBL] [Abstract][Full Text] [Related]
12. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
[TBL] [Abstract][Full Text] [Related]
13. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis.
Gilbert RE; Wu LL; Kelly DJ; Cox A; Wilkinson-Berka JL; Johnston CI; Cooper ME
Am J Pathol; 1999 Aug; 155(2):429-40. PubMed ID: 10433936
[TBL] [Abstract][Full Text] [Related]
14. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
Yilmaz MI; Saglam M; Sonmez A; Caglar K; Cakir E; Kurt Y; Eyileten T; Tasar M; Acikel C; Oguz Y; Vural A; Yenicesu M
Blood Purif; 2007; 25(4):327-35. PubMed ID: 17709915
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Thibault G; Haass M; Höhnel K; Bohlender J; Luft FC; Dietz R
Cardiovasc Res; 1999 Jun; 42(3):733-42. PubMed ID: 10533614
[TBL] [Abstract][Full Text] [Related]
16. [Angiotensin II receptor blockers: current status and future prospects].
Corvol P; Plouin PF
Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
[TBL] [Abstract][Full Text] [Related]
17. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Endlich K; Steinhausen M
J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
Siragy HM; Xue C; Abadir P; Carey RM
Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene.
Peng H; Carretero OA; Alfie ME; Masura JA; Rhaleb NE
Hypertension; 2001 Mar; 37(3):974-80. PubMed ID: 11244026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
